Ascentage Pharma Group International (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

16.72

-0.33 (-1.94%)

At close: Jun 26, 2026, 4:00 PM EDT

16.77

+0.05 (0.30%)

After-hours: Jun 26, 2026, 4:10 PM EDT

AAPG Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,470	1,261	1,094	1,492	1,744
Cash & Short-Term Investments	2,470	1,261	1,094	1,492	1,744
Cash Growth	95.85%	15.30%	-26.70%	-14.43%	70.23%
Accounts Receivable	252.94	83.14	145.89	54.36	53.97
Inventory	28.62	6.6	16.17	9.45	3.93
Other Current Assets	192.53	123.21	88.29	80.44	83.56
Total Current Assets	2,944	1,474	1,344	1,636	1,885
Net Property, Plant & Equipment	829.06	905.56	957.07	648.72	844.37
Other Intangible Assets	65.94	76	85.45	84.3	60.41
Goodwill	24.69	24.69	24.69	24.69	24.69
Long-Term Investments	37.03	33.86	18.95	18.53	27.85
Other Long-Term Assets	62.68	103.54	70.06	417.52	97.46
Total Assets	3,964	2,618	2,500	2,830	2,940
Accounts Payable	106.74	91.97	72.45	95.56	70.86
Accrued Expenses	276.67	258.1	206.91	240.03	194.18
Current Portion of Long-Term Debt	1,222	779.06	616.4	518.38	49.45
Unearned Revenue	37.49	37.49	38.41	24.35	24.36
Other Current Liabilities	-	-	-	2.82	22.26
Total Current Liabilities	1,643	1,167	934.17	881.15	361.11
Long-Term Debt	757.24	889.44	1,179	1,274	1,035
Other Long-Term Liabilities	228.76	287.6	316.4	266.11	309.38
Total Long-Term Liabilities	985.99	1,177	1,496	1,540	1,344
Total Liabilities	2,629	2,344	2,430	2,422	1,705
Common Stock	0.26	0.21	0.2	0.18	0.18
Treasury Stock	-2.96	-0.01	-21.35	-26.55	-0
Additional Paid-in Capital	8,520	6,161	5,580	435.03	1,235
Accumulated Other Comprehensive Income	-179.09	-126.07	-133.02	-	-
Retained Earnings	-7,013	-5,771	-5,365	-	-
Total Common Shareholders' Equity	1,324	264.19	60.42	408.66	1,235
Minority Interest	9.75	9.97	10.22	-	-
Shareholders' Equity	1,334	274.16	70.63	408.66	1,235
Total Liabilities & Equity	3,964	2,618	2,500	2,830	2,940
Total Debt	1,980	1,669	1,796	1,793	1,084
Net Cash (Debt)	490.37	-407.29	-701.76	-300.49	659.53
Net Cash Growth	-	-	-	-	33.32%
Net Cash Per Share	5.51	-5.39	-9.94	-4.56	10.36
Book Value	1,324	264.19	60.42	408.66	1,235
Book Value Per Share	14.88	3.50	0.86	6.20	19.40
Tangible Book Value	1,234	163.5	-49.72	299.66	1,150
Tangible Book Value Per Share	13.86	2.17	-0.70	4.55	18.06

SEC Filings: 10-K · 10-Q